Some peptides are studied together because they do different things well. Here are the combinations that show up most in published research.
The most-published repair peptide combination in research literature.
BPC-157 and TB-500 are studied together because they approach tissue repair from different angles — BPC-157 through localised growth factors, TB-500 through cell migration. Adding GHK-Cu brings collagen support into the mix.
Pre-Blended
BPC-157 + TB-500 Blend 20mg
£59.99Save vs buying separately
Two of the most-studied metabolic peptides combined.
Retatrutide is a triple-agonist (GLP-1, GIP, glucagon) — the first peptide to target all three receptors in a single molecule. Pair it with Cagrilintide (an amylin analogue) and you're covering the two primary metabolic research pathways.
Two Russian-developed neuropeptides that target different brain pathways.
Selank works on serotonin and GABA (calming pathways), Semax works on BDNF and NGF (growth/protection pathways). Researchers study them together because they don't compete — each does something the other doesn't.
Pre-Blended
Selank + Semax Blend 20mg
£44.99Save 25% vs buying separately
Three compounds, three different cellular targets.
NAD+ is the coenzyme that declines with age. MOTS-C is a mitochondrial peptide studied as an exercise mimetic. SS-31 targets the inner mitochondrial membrane directly. Each works at a different level of cellular energy research.
Three peptides studied for different aspects of skin biology.
GHK-Cu is the collagen peptide — it's been studied since the 1970s for skin remodelling. TB-500 brings cell migration research. BPC-157 adds the tissue-healing angle. Our GLOW Blend puts all three in one vial.
Pre-Blended
GLOW Blend 70mg
£69.99Save 18% vs buying separately
Every product ships with a full Certificate of Analysis. Browse individually or build your own combination.
All products are sold strictly for in-vitro research and laboratory use only. Not intended for human or animal consumption. Stacks are curated based on published research literature — Peptify does not make therapeutic claims.